Roman Ivanov, PhD - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(12)

BIOLOGICAL(2)

DRUG(1)

BCD-054 240 mcg

BCD-054 180 mcg

humanized monoclonal antibody against human IL-17

+4 more interventions

12 unique interventions3 categories

Analytics

Trial Phases

Phase 14

Phase 24

Phase 34

Trial Status

Completed11

Role Distribution

Other Roles11

Activity Timeline

Clinical Trials (11)

NCT03519243Phase 2Completed

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

Anemia

StudychairStart date: 2017-10-24

NCT02744222Phase 2/3Completed

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

StudychairStart date: 2017-08-10

NCT03693950Phase 1Completed

The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

Healthy

StudychairStart date: 2017-03-28

NCT02762955Phase 3Completed

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

StudychairStart date: 2016-12-01

NCT02762799Phase 1Completed

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Leucocytosis

StudychairStart date: 2016-07-18

NCT02731469Phase 1Completed

Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

Reticulocyte Count

StudychairStart date: 2016-06-15

NCT02744196Phase 3Completed

Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

StudychairStart date: 2015-01-01

NCT02380287Phase 1Completed

First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects

Healthy

Studychair

NCT02762812Phase 3Completed

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Studychair

NCT02762994Phase 2Completed

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Studychair

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Spondylitis, Ankylosing2 Healthy2 Psoriasis2 Anemia1 Leucocytosis1 Multiple Sclerosis, Relapsing-Remitting1 Reticulocyte Count1 Arthritis, Rheumatoid1

Affiliations

JCS BIOCAD

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hagop Youssoufian, MD

Verastem, Inc.

Shared therapeutic areas:

HealthyArthritis, Rheumatoid

Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Shared therapeutic areas:

PsoriasisArthritis, Rheumatoid

Similarity Score8%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Shared therapeutic areas:

Arthritis, Rheumatoid

Similarity Score4%

Abhik Das, PhD

RTI International

Shared therapeutic areas:

Similarity Score4%

Hamid Gourabi, PhD

head of Royan Institute

Shared therapeutic areas:

Arthritis, Rheumatoid

Similarity Score4%

emilie garrido pradalie

APHM

Shared therapeutic areas:

Similarity Score4%

Waqar ahmed awan, Phd

Riphah International University

Shared therapeutic areas:

Similarity Score4%

Ali MA Ismail, lecturer

Cairo University

Shared therapeutic areas:

Similarity Score4%

Carl T D'Angio, MD

University of Rochester

Shared therapeutic areas:

Similarity Score4%

Murad Alam, MD

Northwestern University

Shared therapeutic areas:

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT03519243Phase 2StudyChair

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

Anemia

Completed

NCT02744222Phase 2/3StudyChair

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Completed

NCT03693950Phase 1StudyChair

The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

Healthy

Completed

NCT02762955Phase 3StudyChair

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Completed

NCT02762799Phase 1StudyChair

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Leucocytosis

Completed

NCT02731469Phase 1StudyChair

Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

Reticulocyte Count

Completed

NCT02744196Phase 3StudyChair

Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Completed

NCT02380287Phase 1StudyChair

First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects

Healthy

Completed

NCT02762812Phase 3StudyChair

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Completed

NCT02762994Phase 2StudyChair

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Completed

NCT02763111Phase 2StudyChair

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

Ankylosing Spondylitis

Completed

All 11 trials loaded